Data ownership, access and control, in addition to consent management, are just a few of the benefits that blockchain can provide in healthcare, says Mirko De Maldè, President at Government Blockchain Association Italy.
Tej Anand, professor of practice at the University of Texas' McCombs School of Business, explains how the most promising use case for blockchain in healthcare is the elimination of "redundant work, rework and reconciliation."
Susanne Somerville, CEO of Chronicled, discusses the MediLedger Network, a blockchain solution that provides product verification to help organizations meet requirements outlined in the upcoming Drug Supply Chain Security Act (DSCSA).
Blockchain ensures greater data integrity in areas such as AI, analytics and regulatory reporting, which can increase public confidence in the use of data, according to Raja Sharif, CEO, FarmaTrust.
David Koepsell, founder and CEO of EncrypGen, discusses the use of blockchain technology to increase the availability of data for basic science and reward customers.
HIMSS Director of Informatics Mari Greenberger says that as pilot tests move into production healthcare organizations should rally around a use case and understand who needs to be involved to reduce redundancies and eliminate sunk costs.
Susan Ramonat, CEO, Spiritus Partners discusses the role blockchain technology can play in supporting supply chain processes by providing access to traceable, verifiable, tamper-evident records across a medical device's entire lifecycle.
Michael Nash, founder and Chief Product Officer of Lumedic, highlights how blockchain and machine learning can be applied to simplify and automate large portions of revenue cycle operations.
Brian de Francesca, CEO of Ver2 Digital Medicine, talks about how telemedicine has evolved and efforts to provide medical care to refugees in camps using a cloud-based electronic health record that was built on blockchain.
David Stefanich, managing partner and CEO of Rymedi, discusses how his company works to capture, track and share data across value chains in the life sciences industry and gives examples of programs currently in production in Mongolia and the US.